Cheng Y F, Huang T L, Chen T Y, Concejero A, Tsang L L C, Wang C C, Wang S H, Sun C K, Lin C C, Liu Y W, Yang C H, Yong C C, Ou S Y, Yu C Y, Chiu K W, Jawan B, Eng H L, Chen C L
Liver Transplantation Program and Department of Diagnostic Radiology, Chang Gung University College of Medicine, Kaohsiung 83305, Taiwan.
Am J Transplant. 2006 Dec;6(12):2994-9. doi: 10.1111/j.1600-6143.2006.01562.x.
Portal hyperperfusion in a small-size liver graft is one cause of posttransplant graft dysfunction. We retrospectively analyzed the potential risk factors predicting the development of portal hyperperfusion in 43 adult living donor liver transplantation recipients. The following were evaluated: age, body weight, native liver disease, spleen size, graft size, graft-to-recipient weight ratio (GRWR), total portal flow, recipient portal venous flow per 100 g graft weight (RPVF), graft-to-recipient spleen size ratio (GRSSR) and portosystemic shunting. Spleen size was directly proportional to the total portal flow (p = 0.001) and RPVF (p = 0.014). Graft hyperperfusion (RPVF flow > 250 mL/min/100 g graft) was seen in eight recipients. If the GRSSR was < 0.6, 5 of 11 cases were found to have graft hyperperfusion (p = 0.017). The presence of portosystemic shunting was significant in decreasing excessive RPVF (p = 0.059). A decrease in portal flow in the hyperperfused grafts was achieved by intraoperative splenic artery ligation or splenectomy. Spleen size is a major factor contributing to portal flow after transplant. The GRSSR is associated with posttransplant graft hyperperfusion at a ratio of < 0.6.
小体积肝移植中的门静脉高灌注是移植后移植物功能障碍的一个原因。我们回顾性分析了43例成人活体肝移植受者中预测门静脉高灌注发生的潜在危险因素。评估了以下因素:年龄、体重、原发病肝脏疾病、脾脏大小、移植物大小、移植物与受者体重比(GRWR)、门静脉总血流量、每100克移植物重量的受者门静脉血流量(RPVF)、移植物与受者脾脏大小比(GRSSR)和门体分流。脾脏大小与门静脉总血流量(p = 0.001)和RPVF(p = 0.014)成正比。8例受者出现移植物高灌注(RPVF流量>250 mL/min/100克移植物)。如果GRSSR<0.6,11例中有5例出现移植物高灌注(p = 0.017)。门体分流的存在对降低过高的RPVF有显著意义(p = 0.059)。通过术中脾动脉结扎或脾切除术可使高灌注移植物的门静脉血流量减少。脾脏大小是移植后门静脉血流的主要影响因素。GRSSR<0.6时与移植后移植物高灌注相关。